Data shows drug slowing Alzheimer’s but doubts over effect remain
Lecanemab modestly slows disease's inevitable worsening, but it remains unclear how much of a difference it will make.Lecanemab modestly slows disease's inevitable worsening, but it remains unclear how much of a difference it will make.